Pacific Biosciences Of California Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pacific Biosciences Of California Inc 's ROA in the second quarter of 2026?
Pacific Biosciences Of California Inc recorded a cumulative net loss of $-131 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -16.82%.

However, within the Healthcare sector 345 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3373, from total ROA ranking in the first quarter of 2026 at 4759.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-8.92 %	-9 %	-37 %	-44.07 %	-44.57 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-131	-129	-546	-504	-526
Return On Assets (TTM)	-16.82 %	-16.08 %	-66.72 %	-53.91 %	-48.18 %
PACB's Total Ranking	# 3373	# 4759	# 4056	# 4054	# 4176
Total Assets (TTM) in million	752	784	786	803	825
Seq. Total Assets Change	-4.1 %	-0.21 %	-2.18 %	-2.7 %	-4.18 %
Seq. Net Income Change	-	-	-	-	-

PACB's 5 Years Annual ROA >> Back to PACB Management Effectiveness >> Compare PACB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 17
Sector	# 346
Overall	# 3368

Return On Assets Statistics
High	Average	Low
10.12 %	-38.48 %	-68.3 %
(Dec 31 2020)		(Sep 30 2019)

Financial Statements
Pacific Biosciences Of California Inc 's Assets	$ 752 million	PACB's Balance sheet
Pacific Biosciences Of California Inc 's Income	$ -45 million	Quarterly PACB's Income Statement
PACB's Income by Division		See PACB's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-37 %	-27.33 %	-0.85 %	-11.84 %	408.62 %
Total Assets in million	786	1,247	1,716	1,731	1,963
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-546	-310	-307	-314	-181
Annual Return On Assets	-69.55 %	-24.85 %	-17.87 %	-18.16 %	-9.23 %

PACB's 5 Years Annual ROA >> Back to PACB Management Effectiveness >> Compare PACB ROA to its Competitors

More Return On Assets Ratios
PACB's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PACB's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PACB's Competitors
Subscribers only: Roa for Pacific Biosciences Of California Inc 's Suppliers
Subscribers only: Return On Assets for PACB's Customers

You may also want to know
PACB's Roi	PACB's Inventory Turnover Ratio	PACB's Growth Rates	PACB's Dividend Comparisons
	PACB's Profitability Ratios	PACB's Asset Turnover Ratio	PACB's Dividend Growth
PACB's Roe	PACB's Valuation Ratios	PACB's Financial Strength Ratios	PACB's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:13:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.